The FinTech Hub
Source: Live Mint Stock Market Today: Indian pharma stocks faced significant selling pressure in today’s session, February 10, driven by weak earnings in select companies and fears that former U.S. President Donald Trump could introduce a universal trade tariff of at least 10% on all imports, potentially affecting pharmaceutical exports. As a result, 19 out…
Source: Live Mint Stocks to buy: The Indian stock market remained under selling pressure for the fourth straight session on Monday, February 10, with the Sensex declining over 600 points and the Nifty 50 approaching 23,350 during intraday trade. The BSE benchmark Sensex opened at 77,789.30, slightly lower than its previous close of 77,860.19, before…
Source: Live Mint Three stocks to buy, recommended by Ankush Bajaj: Buy Voltas buy at 1835 tgt 1885-1910 sl 1760. stock has broken imp level of 1810 with good volume we might see a good up trend. Auropharma buy at 1348 tgt 1405-1426 sl 1320. based on recent bullishness of Pharma sector I have picked…
Source: Live Mint Market recap: 1 February Source: TradingView The Indian stock market closed on the upside, with the Auto and IT and Consumption sectors pulled the market up. The Nifty 50 index closed at 24,188.65 while the BSE Sensex closed at 79,943.71, up 1.83%. Nifty Media sectors underperformed the market and closed in red….
Source: Live Mint Stock market today: On Tuesday, the Indian stock market extended its gains for the second consecutive trading session. The Nifty 50 rose by 0.42 percent, ending the day above the 25,000 mark at 25,041 points. The BSE Sensex also closed higher, climbing 0.43 percent to reach 81,912 points. Trade setup for Wednesday…
Source: Business Standard 4 min read Last Updated : Sep 10 2024 | 1:59 PM IST Shares of pharmaceutical companies as well as contract drug manufacturing companies (CDMOs) experienced significant gains in intraday trade on Tuesday, after a double dose of good news on the domestic as well US market front. On Monday the 54th…
